Biological behavior of keratoacanthoma and squamous cell carcinoma: telomerase activity and COX-2 as potential markers
- 1 April 2004
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 17 (4) , 468-475
- https://doi.org/10.1038/modpathol.3800063
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Keratoacanthomas Frequently Show Chromosomal Aberrations as Assessed by Comparative Genomic HybridizationJournal of Investigative Dermatology, 2002
- Telomerase activity, MIB‐1, PCNA, HPV 16 and p53 as diagnostic markers for cervical intraepithelial neoplasiaNoteAPMIS, 2001
- Differences between Squamous Cell Carcinoma and Keratoacanthoma in Angiotensin Type-1 Receptor ExpressionThe American Journal of Pathology, 2001
- Telomerase Activity in Melanocytic LesionsThe American Journal of Pathology, 2000
- Differentiating Squamous Cell Carcinoma from Keratoacanthoma Using Histopathological CriteriaDermatology, 1999
- A survey of telomerase activity in human cancerPublished by Elsevier ,1997
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- Differential diagnosis of keratoacanthomas and squamous cell carcinomas: diagnostic value of DNA image cytometry and p53 expressionJournal of Cutaneous Pathology, 1994
- Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinomaBritish Journal of Dermatology, 1992
- Mutant p53—the commonest genetic abnormality in human cancer?The Journal of Pathology, 1990